Bethany E Higgins1, Deanna J Taylor1, Alison M Binns1, David P Crabb2. 1. Optometry and Visual Sciences, School of Health Sciences, City, University of London, London, UK. 2. Optometry and Visual Sciences, School of Health Sciences, City, University of London, London, UK. david.crabb.1@city.ac.uk.
Abstract
INTRODUCTION: Dark adaptation (DA) has been proposed as a possible functional biomarker for age-related macular degeneration (AMD). In this systematic review we aim to evaluate current methodology used to assess DA in people with AMD, the evidence of precision in detecting the onset and progression of AMD, and the relationship between DA and other functional and structural measures. METHODS: MEDLINE, EMBASE, CINAHL, AMED, PsycINFO, PsycARTICLES were searched for studies published between January 2006 and January 2020 that assessed DA in people with AMD. Details of eligible studies including study design, characteristics of study population and outcomes were recorded. All included studies underwent quality appraisal using approved critical appraisal tools. This systematic review follows PRISMA guidelines (PROSPERO registration number: CRD42019129486). RESULTS: Forty-eight studies were eligible for inclusion, reporting a variety of instruments and protocols to assess different DA parameters. Twenty of these studies used the AdaptDx (MacuLogix, Hummelstown, PA, USA) instrument and assessed rod-intercept time (RIT). Most of these reported that RIT was delayed in people with AMD and this delay worsened with AMD severity. Four studies, involving 533 participants, reported estimates of diagnostic performance of AdaptDx to separate people with AMD from visually healthy controls. DA has been compared to other measures of visual function, patient-reported outcome measures (PROMs) and structural measures. Ten studies specifically considered evidence that the presence of certain structural abnormalities was associated with impaired DA in AMD. CONCLUSIONS: This systematic review indicates overwhelming evidence of reasonable quality for an association between impaired DA and AMD. Data on the repeatability and reproducibility of DA measurement are sparse. There is evidence that structural abnormalities such as reticular drusen are associated with prolongation of DA time. Fewer studies have explored an association between DA and other measures of visual function or PROMs. We found no studies that had compared DA with performance-based measures.
INTRODUCTION: Dark adaptation (DA) has been proposed as a possible functional biomarker for age-related macular degeneration (AMD). In this systematic review we aim to evaluate current methodology used to assess DA in people with AMD, the evidence of precision in detecting the onset and progression of AMD, and the relationship between DA and other functional and structural measures. METHODS: MEDLINE, EMBASE, CINAHL, AMED, PsycINFO, PsycARTICLES were searched for studies published between January 2006 and January 2020 that assessed DA in people with AMD. Details of eligible studies including study design, characteristics of study population and outcomes were recorded. All included studies underwent quality appraisal using approved critical appraisal tools. This systematic review follows PRISMA guidelines (PROSPERO registration number: CRD42019129486). RESULTS: Forty-eight studies were eligible for inclusion, reporting a variety of instruments and protocols to assess different DA parameters. Twenty of these studies used the AdaptDx (MacuLogix, Hummelstown, PA, USA) instrument and assessed rod-intercept time (RIT). Most of these reported that RIT was delayed in people with AMD and this delay worsened with AMD severity. Four studies, involving 533 participants, reported estimates of diagnostic performance of AdaptDx to separate people with AMD from visually healthy controls. DA has been compared to other measures of visual function, patient-reported outcome measures (PROMs) and structural measures. Ten studies specifically considered evidence that the presence of certain structural abnormalities was associated with impaired DA in AMD. CONCLUSIONS: This systematic review indicates overwhelming evidence of reasonable quality for an association between impaired DA and AMD. Data on the repeatability and reproducibility of DA measurement are sparse. There is evidence that structural abnormalities such as reticular drusen are associated with prolongation of DA time. Fewer studies have explored an association between DA and other measures of visual function or PROMs. We found no studies that had compared DA with performance-based measures.
Entities:
Keywords:
AMD; AdaptDx; Age-related macular degeneration; Dark adaptation; Dark adaptometer; Rod-intercept time; Systematic literature review
Authors: Robert P Finger; Steffen Schmitz-Valckenberg; Matthias Schmid; Gary S Rubin; Hannah Dunbar; Adnan Tufail; David P Crabb; Alison Binns; Clara I Sánchez; Philippe Margaron; Guillaume Normand; Mary K Durbin; Ulrich F O Luhmann; Parisa Zamiri; José Cunha-Vaz; Friedrich Asmus; Frank G Holz Journal: Ophthalmologica Date: 2018-08-28 Impact factor: 3.250
Authors: Jason Flamendorf; Elvira Agrón; Wai T Wong; Darby Thompson; Henry E Wiley; E Lauren Doss; Shaza Al-Holou; Frederick L Ferris; Emily Y Chew; Catherine Cukras Journal: Ophthalmology Date: 2015-08-04 Impact factor: 12.079
Authors: Gregory R Jackson; Mark E Clark; Ingrid U Scott; Laura E Walter; David A Quillen; Mitchell G Brigell Journal: Optom Vis Sci Date: 2014-08 Impact factor: 1.973
Authors: John D Rodriguez; Keith Lane; David A Hollander; Aron Shapiro; Sunita Saigal; Andrew J Hertsenberg; Garrick Wallstrom; Divya Narayanan; Endri Angjeli; Mark B Abelson Journal: Clin Ophthalmol Date: 2018-07-27